Targeting the Notch Pathway: Killing Cancer Stem

Jan 2, 2016 - Radio: lower levels of ROS were detected in CSC enriched human breast cancer samples after radiation relative to non-CSC ..... REGN421...

0 downloads 0 Views 7MB Size

Recommend Documents

Other transcriptional regula- tors influence .... Notch promotes EMT through the regula- ..... Hopfer O, Zwahlen D, Fey MF, Aebi S. The Notch pathway in ovarian.

efficiently form soft-agar colonies or tumor xenografts, suggesting that a cell .... 12-well tissue culture plates and allowed to adhere overnight. After treating ..... analysis of Annexin staining, suggesting that our manual counting procedure is ..

Notch signaling pathway in pancreatic cancer with a special ...... piperine. Breast Cancer Res Treat 122: 777-785, 2010. 81 Bao B and Sarkar F: Anti-tumor ...

May 30, 2013 - EMT, it has been reported that Midkine-Notch-2 interaction activated. Notch signaling and subsequently induced EMT in PC cells [28]. Recently ...

Abstract. Increasing evidence suggests that many types of cancers contain a population of cells that display stem cell properties. These cells are called cancer stem cells (CSCs). They are virtually resistant to radiation, and may contribute to treat

Abstract. There is no radical cure for all cancer types. The most frequently used therapies are surgical treatment, radio- therapy and chemotherapy. However, recrudescence, radiation resistance and chemotherapy resistance are the most chal- lenging i

Feb 15, 2015 - systems are not wholly precise, it also results in quite a few side effects, and is less efficient in many cancers due .... CD133. Brain tumors [34, 117, 118], prostate [119], colon [36, 120], lung [121], melanoma [90], pancreatic [26]

Nov 15, 2015 - with the Pearson correlation. To assess whether the means of 2 groups were statistically different from each other, we used the Student t test. ..... Rodilla V, Villanueva A, Obrador-Hevia A, et al. Jagged1 is the pathological link bet

Jun 27, 2012 - The HER2-PI3K pathway is the one of the most mutated pathways in cancer. Several drugs targeting the major kinases of this pathway have ...

Feb 15, 2010 - and the RB status played a role in the response to flavopri- dol (63). However, such ... 6 http://www.cancer.gov/clinicaltrials. RB-Pathway and ..... Morris EJ, Michaud WA, Ji JY, Moon NS, Rocco JW, Dyson NJ. Functional ...

Jan 2, 2014 - Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Kodappully .... in multiple cellular pathways leading to changes in growth, differen- tiation and apoptosis [3–6]. ...... gastritis, stomach ca

Jul 18, 2006 - S.; Metro, G.; Crino, L. Oncology (Williston Park), 2005, 19, 989 - ... Robinson, M.K.; Weiner, L.M.; Adams, G.P. Drug Development. Research ...

Cancer stem cells (CSC) or “tumor-initiating cells” have been identified in ...... A phase I first-in-human study of enoticumab (REGN421), a fully human delta-like ...

new treatment modalities in the form of nanoparticles (NPs)-targeting CSC-specific markers or signaling ...... J Exp. Clin Cancer Res. 2005;24(3):415–421. 127.

Aug 17, 2010 - ation and induce cell differentiation in several cancer models, both in ... The human SH-SY5Y neuroblastoma cell line (DSMZ) was cultured in a ...

mon, but not defining, characteristics of CSCs such as rarity, stem cell markers, and ... kinase fusion proteins (FGFR-TACC3) as genetic drivers and targets of CSCs (17), in addition ..... cancer stemness inhibitors, including BBI608 (inhibitor of St

Sep 9, 2007 - Csl targets include the Hairy and Enhancer of split (Hes) and Hes- related (Hey) ... phosphatidylinositol 3-kinase pathway (Foxo) and the Hes/Hey pathway ..... and Accili, D. 2003. Regulation of insulin-like growth factor-dependent myob

on June 22, 2017. © 2006 American Association for Cancer Research. ..... which contains the tumor- suppressor gene PTEN, and the BioCarta pathway ''Cell.

Jul 6, 2016 - disease-free survival of the patients with IHC defined activated ..... Mutational landscape of gingivo-buccal oral squamous cell carcinoma ...

May 4, 2017 - zin (7-O-glucosyl-4-hydroxyisoflavone), isolated from Pueraria lo- bata and Glycine max (Fabaceae), is a potent inhibitor of ALDH2 with an IC50 of 80 ... by a fungal species of the genus Coprinus and Coprinopsis (Agarica- ceae), was not

Jun 5, 2013 - THEREOF. This patent has been licensed to Almac Discovery. Financial support: LMcC was awarded a PhD studentship from the Department of Employment and ... reducing mammosphere forming efficiency (MFE) and ESA+/CD44+/CD24- or ALDH+ cell

Feb 14, 2013 - effect on tumor growth of the bulk tumor population in advanced stages of cancer, but may have ... may act in concert to eradicate CSCs, more differentiated progenitors and bulk tumor cells in cancer ...... Kopecek J. Selective inhibit

The Hedgehog (Hh) signaling pathway plays a pivotal .... The current definition of GSCs is based on ..... antagonists including TAK-441, LEQ506, PF-04449913,.

Jun 21, 2016 - the bulk of the tumor cells while maintaining their own ... co-delivering two inhibitors to target two distinct populations within tumor bulk. Current studies involve the combination of immunotherapy and existing chemotherapeutic drug